Equity Research Asset Management

Should You Buy Calamos Long/Short Equity & Dynamic Income Term Trust Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Calamos Long/Short Equity & Dynamic Income Term Trust (CPZ) sits in the bottom tier of our quality coverage with a score of 2.2/10. While a weak quality score suggests operational challenges, our valuation models assess if the market has over-discounted the stock at $12.73.

The short answer: 0 of 1 CirclFi valuation models project upside for Calamos Long/Short Equity & Dynamic Income Term Trust (CPZ) at $12.73 — the model consensus leans bearish, with a Quality Score of 2.2/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models suggest overvaluation — majority bearish
  • Quality Score: 2.2/10 — Very Weak — significant concerns
  • Value Trap Risk: 0/100 — Minimal — healthy fundamentals
  • Fair Value Range: $12.73 – $12.73 (0% spread)

Bullish Models

0 / 1

Bearish Models

1 / 1

Quality Score

2.2 /10

Very Weak — significant concerns

Value Trap Risk

0 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

1 /13
Active Models

Avg. confidence: 7%

What Is the Investment Case for Calamos Long/Short Equity & Dynamic Income Term Trust (CPZ) in 2026?

What Is the Bull Case vs the Bear Case for Calamos Long/Short Equity & Dynamic Income Term Trust (CPZ)?

Bull case versus bear case for Calamos Long/Short Equity & Dynamic Income Term Trust (CPZ) at $12.73, derived from 1 active CirclFi valuation models on 2026-09-15.
Bull case Bear case — $12.73 target (-0.0%)
No active model projects meaningful upside for CPZ at $12.73. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. According to the CirclFi Quality of Company (QOC) framework, Calamos Long/Short Equity & Dynamic Income Term Trust's rating of 2.2/10 indicates below-average quality, raising questions about sustainable earnings levels.

How Does CPZ Compare to Its Asset Management Peers?

BCX Blackrock Resources
2.2
RGT Royce Global Trust,
2.2
BMEZ BlackRock Health Sci
2.2
IGI Western Asset Invest
2.2
GRX The Gabelli Healthca
2.2
BSTZ BlackRock Science an
2.2
AAMI Acadian Asset Manage
7.6
STEP StepStone Group Inc.
6.0

Valuation data pages: BCX · RGT · BMEZ · IGI · GRX · BSTZ · AAMI · STEP · CYPH · HLNE · AMP

See full Asset Management rankings →

Which Other Stocks Score Like CPZ on Quality?

Closest companies to CPZ’s Quality of Company score of 2.2/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on CPZ?

Spread

0%

Fair Value Range

$12.73 – $12.73

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

Markov DDM

$12.73 (-0.0%)

Most Bearish

Markov DDM

$12.73 (-0.0%)

What Are the Biggest Risks of Buying CPZ Stock?

Weak Fundamentals

QOC 2.2/10 signals below-average quality.

Bearish Consensus

1/1 models suggest overvaluation.

Macro/Sector Risk

Asset Management headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View CPZ Data Page →

So Is Calamos Long/Short Equity & Dynamic Income Term Trust (CPZ) Worth Buying in 2026?

Our models don't have a clear verdict on Calamos Long/Short Equity & Dynamic Income Term Trust. At $12.73 vs. $12.73 median fair value, the median upside of -0.0% masks significant model disagreement (+0.0% spread). With quality at 2.2/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.

These are quantitative model outputs, not investment recommendations. Calamos Long/Short Equity & Dynamic Income Term Trust's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About CPZ Stock?

Should I buy CPZ stock right now?

Based on CirclFi's multi-model analysis, 0 of 1 models see upside for CPZ at $12.73. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Calamos Long/Short Equity & Dynamic Income Term Trust?

Key risks include: a below-average Quality Score of 2.2/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Asset Management companies. Always diversify and consult a financial advisor.

How does CPZ compare to its competitors?

Among Asset Management peers, CPZ holds a Quality Score of 2.2/10. Comparable companies include BCX (QOC 2.2), RGT (QOC 2.2), BMEZ (QOC 2.2). The relative ranking helps investors identify whether CPZ offers better fundamental quality than alternatives in the same sector.

Is CPZ a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CPZ's Quality Score of 2.2/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.

What price should I buy CPZ at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $12.73 to $12.73. At $12.73, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for CPZ.

View CPZ Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →